Schizophrenia

Schizophrenia is a chronic debilitating disorder which affects more than two million Americans, and millions more worldwide. While significant progress has been made in understanding the disease and developing treatments, there remains a significant unmet medical need. More than 50% of patients switch their medication in a given year due to either poor response or the experience of adverse events.

Schizophrenia

Schizophrenia is a chronic mental health disorder that causes people to think, feel and perceive the world differently from the general population.

Schizophrenia Diagnosis

Schizophrenia Causes

Schizophrenia Signs and Symptoms

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments.

8 Aug 2022

When mental illness leads to dropped charges, patients often go without stabilizing care

For seven years, Timothy Jay Fowler rotated between jail, forced psychiatric hospitalization, and freedom.

4 Aug 2022

BBRF hosts a free webinar on manipulating memories to help treat brain illness

The Brain & Behavior Research Foundation is hosting a free webinar, "Manipulating Memories to Help Treat Brain Illness" on Tuesday, August 9, 2022, at 2:00 pm EDT.

3 Aug 2022

Neurons show rhythmic activity at different frequencies in the desynchronized state

In the 17th century, the Dutch scientist Christiaan Huygens hanged two of his recently invented pendulum clocks on a wooden beam and observed that as time passed, the clocks aligned their beats.

2 Aug 2022

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/Medical University of Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder.

2 Aug 2022

Researchers characterize a novel gene likely to cause neurological disorders in humans

A multidisciplinary study led by Vanja Nagy (LBI-RUD/CeMM/MedUni Vienna) and Josef Penninger (UBC/IMBA) characterized a novel gene, known as FIBCD1, to be likely causative of a new and rare neurodevelopmental disorder. Using data from two young patients with neurological symptoms, the researchers from both groups found evidence of a novel function for the FIBCD1 gene in the brain, and a potentially pivotal role in diseases such as autism, ADHD, schizophrenia, and neurodegenerative disorders including Alzheimer's. The study makes an important contribution to the understanding of the extracellular matrix in the brain and its associated neurological diseases.

2 Aug 2022

Brain & Behavior Research Foundation recognizes exceptional research in mental illness

The Brain & Behavior Research Foundation today announced the winners of its 2022 Klerman and Freedman Prizes, recognizing exceptional clinical and basic research in mental illness.

1 Aug 2022

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

People who use high potency cannabis more likely to experience addiction, psychotic disorder

As the strength or potency of cannabis products has increased internationally over the years, so have rates of people being treated for cannabis addiction, say the authors of a new study.

26 Jul 2022

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

A new study aimed to determine the clinical applications of psychedelic drugs along with psychedelic-assisted therapy for different psychiatric disorders.

25 Jul 2022

New research may lead to early diagnosis of devastating mental health conditions

New research by Georgia State University's TReNDS Center may lead to early diagnosis of devastating conditions such as Alzheimer's disease, schizophrenia and autism-; in time to help prevent and more easily treat these disorders.

22 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Researchers discover specific cells that regulate the transmission of information between brain areas

A scientific team from MedUni Vienna's Center for Brain Research has now identified specific cells that regulate the transmission of information between brain areas.

15 Jul 2022

Brain ripples may help integrate information across the cortex during sleep, waking, and memory recall

A fundamental mystery of the human cortex is how its 16 billion neurons integrate or bind the many different kinds of information they encode into a single coherent unified experience or memory.

8 Jul 2022

Gun safety ‘wrapped in a mental health bill’: A look at health provisions in the new law

The gun safety law forged through tense bipartisan talks in the Senate last month has been heralded as the first federal legislation in 30 years to combat rising gun violence. But what often falls below the radar is the new law's focus on improving mental health services.

7 Jul 2022

Schizophrenia

Overview

Schizophrenia Diagnosis

Schizophrenia Causes

Schizophrenia Signs and Symptoms

Feature Articles

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

When mental illness leads to dropped charges, patients often go without stabilizing care

BBRF hosts a free webinar on manipulating memories to help treat brain illness

Neurons show rhythmic activity at different frequencies in the desynchronized state

Study identifies pivotal role of FIBCD1 gene in neurodevelopmental disorders

Researchers characterize a novel gene likely to cause neurological disorders in humans

Brain & Behavior Research Foundation recognizes exceptional research in mental illness

Repurposing an antipsychotic drug to treat various types of cancer

People who use high potency cannabis more likely to experience addiction, psychotic disorder

What is the role of psychedelic drugs in the treatment of psychiatric disorders?

New research may lead to early diagnosis of devastating mental health conditions

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Researchers discover specific cells that regulate the transmission of information between brain areas

Brain ripples may help integrate information across the cortex during sleep, waking, and memory recall

Gun safety ‘wrapped in a mental health bill’: A look at health provisions in the new law

IU neuroscientists receive $2 million to better understand the impact of cannabis use during adolescence

Repeat nursing homes transfers are much higher for Black residents and those under age 65, study finds

New therapy approaches can help when medicine is not enough for schizophrenia and psychosis

California may require labels on pot products to warn of mental health risks

Research offers new insights into how the brain interprets motion during self-motion

Costly Chemicals; The Health and Economic Impact of 'Forever Chemicals'

Crying out for new disease diagnoses

Understanding the emotions behind memories

Schizophrenia

Overview

Feature Articles

Schizophrenia Neural Processes

Schizophrenia Mechanisms

Schizophrenia Screening, Prevention and Management

Schizophrenia Medication

Schizophrenia Interventions

Schizophrenia Prognosis

Latest Schizophrenia News and Research

Costly Chemicals; The Health and Economic Impact of 'Forever Chemicals'

Crying out for new disease diagnoses

Understanding the emotions behind memories

Newsletters you may be interested in